Medicinal Signaling Cells (MSCs) are basic human cells that have the potential to create new cells in existing healthy tissue and have an important role in helping heal injured ligaments, tendons, tissues and bones. MSC regenerative therapy allows the treating physician to deliver a high concentration of these specialized cells directly in a damaged area.
The science and use of MSC treatment continues to evolve and change, but the future for this biologic therapy looks promising.
Medicinal signaling cell treatment is a minimally invasive procedure. Dr. Getelman uses this technique for revision or complex surgical patients and performs regenerative cell therapy by extracting the cells from the bone marrow in a patient’s pelvis. The harvested cells are then injected directly into the injured area to facilitate healing.
Medicinal signaling cell therapy is also used at The Southern California Orthopedic Institute in a unique way during rotator cuff repair surgery. Dr. Getelman always includes the activation of a “Crimson Duvet” in their “SCOI Row” for rotator cuff tendon repairs. The Crimson Duvet is a rich, healing bone marrow augmentation that contains growth factors, new blood supply and MSCs. This technique is proven to give new circulation and helps heal rotator cuff tears. You can learn more about Crimson Duvet here.
It is important to note medicinal signaling cell therapy risks are extremely low since a patient’s own cells are used in the damaged area. However, regenerative cell treatment is not ideal for all patients. At a patient’s consultation, Dr. Getelman will discuss the indications, potential benefits and risks of any medicinal signaling cell therapy, as well as determine if the patient’s injury can be treated with this regenerative medicine technique.
For more information on medicinal signaling cell therapy, or for additional information on the Crimson Duvet treatment, please contact Dr. Mark Getelman, orthopedic specialist in the Van Nuys, Westlake Village, Thousand Oaks and Los Angeles, California area.